(Published in Part II, Section 3, Sub-section (ii) of

the Gazette of India, Extraordinary, dated the 30^th November, 2007)

Government of India

Ministry of Chemicals and Fertilizers

National Pharmaceutical Pricing Authority

New Delhi, the 30^th November, 2007

ORDER

S.O. 2060(E)- In partial modification to S.O. No. 1648(E) dated 27^th September, 2007 the entries in the table at Sr. No. 1 may be read as :

Table

Sl. No.	Name of the formulation	Strength	Pack   Size	Ceiling Price (Rs.)	Equivalent MRP*  inclusive  of all taxes  (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
--	--	Each capsule contains	--	--	--
1	Doxycycline Capsule	Doxycycline HCl/Hyclate  E.q. to Doxycycline 100mg	10’s Strip/Blister	8.82	10.17”

*Subject to actual payment of Government levies/taxes, as applicable.

 Note :

(a)        For addition of ingredient like Lactic Acid Bacillus Rs.0.017 per 10’s tablet/capsule will be added/substracted for each 10 million spores or part thereof of Lactic Acid Bacillus as the case may be in the above mentioned formulation packs.

(b)        The prices fixed are the maximum retail prices in column (6) (inclusive of excise duty and local taxes if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.

(c)        The companies / manufacturers may added taxes only if they have paid actually to the Government on the price mentioned in the column (5).  If there is any variation in the MRP (inclusive of the taxes), the same may be intimated to the NPPA in the Form-V of DPCO, 1995.

(d)        Pro-rata pricing for packs of same composition but of different sizes will be applicable vide S.O. No. 83(E) dated 27.1.1998 for tablet and capsule packed in strip/blister.

(e)        For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.

(f)         The prices fixed/notified hereinabove under the provisions of DPCO, 1995 have to be mandatorily implemented by the manufacturing /marketing company notwithstanding its status of compliance of conditions for such formulation pack under the Drugs and Cosmetics Act, 1940.

(g)        The manufacturer and marketing company for the above said formulation shall be required to take the requisite prior approval from the competent Authority for any change in the composition of the above said formulation with written prior intimation to the National Pharmaceutical Pricing Authority.

(h)        Consequent to the issue of ceiling price of the formulation pack(s) in this notification, the following price order(s) issued prior to this date of notification stand automatically withdrawn :

Sl.No.	Price Order No.	Date
.	--	--

 .and any other price order(s) issued earlier for the composition of the formulation pack for which ceiling price is notified in this notification.

PN/97/2007/F

F. No. 8(7)/2007/D.P./NPPA-Div.-II

                                                                                                              (RAJIV WADHAWAN)

                                                                                                                     Deputy Director

Last Page Updated: 01-06-2019